Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized Sunitinib Schedule in Metastatic Renal Cell Carcinoma
NCT01499121Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- May 2012
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Sunnybrook Health Sciences Centre. Started May 2012; status: completed.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01499121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499121.